<strong>Creativity</strong> and <strong>Innovation</strong><br /> for the patient Development of <strong>new therapies</strong> and <br /><strong>treatments</strong> to improve citizens health <strong>Internationally renowned</strong><br /> biomedical research

Creativity and Innovation
for the patient

Development of new therapies and
treatments to improve citizens health

Internationally renowned
biomedical research

Home

Arantza Portillo Barrio

Arantza Portillo Barrio

Aránzazu Portillo

Email: aportillo@riojasalud.es

Phone: +34 941 278 871 (Ext.:89871)

Biosketch

Aránzazu Portillo got the Degree on Biological Sciences at the University of Navarra in 1996. During her PhD thesis research in Biochemistry and Molecular Biology at the University of La Rioja (Spain), supervised by Prof. Carmen Torres and Prof. Fernanda Ruiz, she studied mechanisms of resistance to macrolide, lincosamide and streptogramin (MLS) in streptococci and enterococci, under financial support of the Ministry of Education and Culture (MEC). In 1999, she was awarded a grant from the Spanish Agency of International Cooperation (AECI) for a 2-month stay at the National University of Piura (Perú). In 2000, she enjoyed a 7-month stay funded by MEC at Pfizer Global Research and Development Pharmaceutical Laboratories in Groton, CT (USA) under supervision of Dr. Joyce A. Sutcliffe. She obtained her doctorate in 2002, when she started to work as the responsible researcher in the setting up of the Special Pathogens Laboratory, attached to the Infectious Diseases Department under supervision of Dr. José A. Oteo. Currently, this lab (called Center of Rickettsiosis and Arthropod-Borne Diseases) is located at CIBIR, and it is equipped with the latest technologies in molecular biology and with a biosafety 3-level facility for the culture of dangerous microorganisms. She is devoted to the study of diseases transmitted by arthropods like rickettsiosis, Lyme disease, Bartonella infections, anaplasmosis, Q fever or Crimean Congo Hemorrhagic Fever (CCHF), among others, as part of a multidisciplinary team. She leads as main researcher the development of molecular, serological and culture methods to give support to the diagnosis of these infections in the framework of the EMER Programme for emergent research groups from the National System of Health (SNS), accredited by the Instituto de Salud Carlos III. She has been actively involved in the implication of new microorganisms in human pathology (Rickettsia rioja) or in the detection of microorganisms in ticks for the first time in our country (CCHF virus and Candidatus Neoehrichia mikurensis) or in the description of new bacteria (Rickettsia sp. strain colombianensi, Rickettsia vini...). She has participated in numerous competitive national and international projects and networks, as collaborator (CYTED, Cost Action EurNegVec…) or as main researcher (FIS PI10-01637). Currently, she is the main researcher with Dr. Oteo of a project funded by the Instituto de Salud Carlos III (FIS PI15-02269) focused on metagenomics of ticks.

She is also member of the Spanish Network for research in infectious Diseases (REIPI) and of the Biological Alert Laboratory Network (RE-LAB), and she is taking part on a project funded by Bayer for the study of Bartonella species under the perspective of One Health.

Since her Ph.D. thesis defense (in 2002) up to the present, she has played tasks teaching and research as part-time professor at the University of La Rioja with intermittent contracts teaching Biochemistry, Experimentation in Biochemistry, Microbiology, Molecular Biology and Biotechnology. She has participated in Ph.D. courses and teaches subjects of Master Degree. She holds ANECA accreditation as Profesor Titular de Universidad, Profesor Ayudante Doctor, Profesor Contratado Doctor and Profesor de Universidad Privada.

She has led three Ph.D. thesis (years 2011, 2012 and 2015) and two Master's Thesis (years 2012 and 2016) and she is involved in the direction of current projects. She has published more than 75 manuscripts in scientific journals with high impact factor and she has served as evaluator of grant agencies and has acted as reviewer in many different scientific journals. She has taken part as guest speaker at national and international meetings: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in 2014 and 2015; Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Congress in 2014, and Society of Infectious Diseases from the North of Spain (SEINORTE) in 2015. She has received awards by different research works from the National Academy of Veterinary from Uruguay (2004), Infectious Diseases Society from Argentina (2006), SEINORTE (2007), and SEIMC (2007 and 2015).

Publications

 

ncbi

 

Date

11 April 2017

Categories

Arthropod Vectors

Partners

La Rioja Crece con Europa. Programa Operativo FEDER de La Rioja, 2014-2020

Unesco, Organización de las naciones unidas para la educación la ciencia y la cultura. Centro Nacional de Documentación y Bioética

Diploma de compromiso con la excelencia

Etiqueta de calificación energética

ISO 14001:2015

© 2021 Rioja Salud - C/ Piqueras, 98 – 3ª Planta · 26006 · Logroño · La Rioja · Telf.: 941 278 855 · Fax: 941 278 887